- Home
- TFFP
as 07-26-2024 4:00pm EST
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 6.3M | IPO Year: | 2019 |
| Target Price: | $44.00 | AVG Volume (30 days): | 20.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.54 - $13.50 | Next Earning Date: | 08-12-2024 |
| Revenue: | $885,715 | Revenue Growth: | 84.60% |
| Revenue Growth (this year): | -40.51% | Revenue Growth (next year): | -29.91% |
Latest TFF Pharmaceuticals Inc. News
TFFP Breaking Stock News: Dive into TFFP Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities
GlobeNewswire
a month ago
TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection
MT Newswires
2 months ago
TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing
GlobeNewswire
2 months ago
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
MT Newswires
2 months ago
TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing
GlobeNewswire
2 months ago
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
GlobeNewswire
2 months ago
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
Zacks
2 months ago
TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates
Compare TFFP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TFFP TFF Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.